Polymeric nanoparticles for targeted drug delivery system for cancer therapy
F Masood - Materials Science and Engineering: C, 2016 - Elsevier
A targeted delivery system based on the polymeric nanoparticles as a drug carrier
represents a marvelous avenue for cancer therapy. The pivotal characteristics of this system …
represents a marvelous avenue for cancer therapy. The pivotal characteristics of this system …
Enriching screening libraries with bioactive fragment space
N Zhang, H Zhao - Bioorganic & Medicinal Chemistry Letters, 2016 - Elsevier
By deconvoluting 238,073 bioactive molecules in the ChEMBL library into extended Murcko
ring systems, we identified a set of 2245 ring systems present in at least 10 molecules …
ring systems, we identified a set of 2245 ring systems present in at least 10 molecules …
Targeting CK2-driven non-oncogene addiction in B-cell tumors
Genetic mutations of oncogenes often underlie deranged cell growth and altered
differentiation pathways leading to malignant transformation of B-lymphocytes. However …
differentiation pathways leading to malignant transformation of B-lymphocytes. However …
Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2
In this article, the derivatives of 3-quinoline carboxylic acid were studied as inhibitors of
protein kinase CK2. Forty-three new compounds were synthesized. Among them 22 …
protein kinase CK2. Forty-three new compounds were synthesized. Among them 22 …
[HTML][HTML] Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses
J Broséus, G Chen, S Hergalant, G Ramstein… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Despite major advances in first-line treatment, a significant proportion of patients with diffuse
large B-cell lymphoma (DLBCL) will experience treatment failure. Prognosis is particularly …
large B-cell lymphoma (DLBCL) will experience treatment failure. Prognosis is particularly …
[HTML][HTML] Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new …
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder promoted by the
constitutive tyrosine kinase activity of Bcr-Abl oncoprotein. Although treatment with the Bcr …
constitutive tyrosine kinase activity of Bcr-Abl oncoprotein. Although treatment with the Bcr …
[HTML][HTML] Quantitative analysis of dynamic protein interactions during transcription reveals a role for casein kinase II in polymerase-associated factor (PAF) complex …
LG Bedard, R Dronamraju, JL Kerschner… - Journal of Biological …, 2016 - ASBMB
Using affinity purification MS approaches, we have identified a novel role for casein kinase II
(CKII) in the modification of the polymerase associated factor complex (PAF-C). Our data …
(CKII) in the modification of the polymerase associated factor complex (PAF-C). Our data …
[HTML][HTML] Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 …
Abstract Interleukin-7 and interleukin-7 receptor are essential for normal T-cell development
and homeostasis, whereas excessive interleukin-7/interleukin-7 receptor-mediated …
and homeostasis, whereas excessive interleukin-7/interleukin-7 receptor-mediated …
Rational design of coumarin derivatives as CK2 inhibitors by improving the interaction with the hinge region
N Zhang, W Chen, Y Zhou, H Zhao… - Molecular …, 2016 - Wiley Online Library
Abstract Design of novel coumarin derivatives as CK2 inhibitors were attempted by targeting
the interaction with the hinge region. A set of substituents capable of forming a hydrogen …
the interaction with the hinge region. A set of substituents capable of forming a hydrogen …
[PDF][PDF] OptimalIL-7R-mediatedsignaling, cellcycleprogressionandviabilityofT-cellacute lymphoblasticleukemiacellsrelyonCK2activity
Interleukin-7 and IL7R are essential for normal T-cell development and homeostasis,
whereas excessive interleukin-7/IL7R-mediated signaling promotes leukemogenesis …
whereas excessive interleukin-7/IL7R-mediated signaling promotes leukemogenesis …